Mundipharma’s consumer health bought by iNova for $810m

business acquisitions handshake
Funds from Betadine purchase to be held in escrow to bankroll opioid crisis recompense iNova has bought Mundipharma International’s consumer health care business, centred around the Betadine product range for a USD$540 million (AUD$810 million). According to a release from iNova, Mundipharma’s beneficial owners and iNova “have agreed that all the net sale proceeds will

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Semaglutide cancer and depression risks investigation
Next Skerritt’s successor slips in unannounced